DUCTAL CARCINOMA IN-SITU OF THE BREAST - HISTOLOGIC CATEGORIZATION AND ITS RELATIONSHIP TO PLOIDY AND IMMUNOHISTOCHEMICAL EXPRESSION OF HORMONE RECEPTORS, P53, AND C-ERBB-2 PROTEIN

Assessments of aromatase expression in ductal carcinoma in situ (DCIS) and invasive ductal carcinoma (IDC) in 162 cases using semi-quantitative immunohistochemistry found aromatase

Em jeito de apreciação final, no período de 17 anos (1976-1993) até à criação do INDESP, a administração pública desportiva, teve uma única estrutura de base, a

Contra diversos historiadores anteriores, citados no início deste artigo, Rojas argumenta que as decisões de deixar o Peru e a Argentina foram tomadas para não só evitar novos

In the present study, positive membranous expression of N-cadherin was detected in 51.9% of invasive ductal breast carcinoma samples and was associated with poor histologic...

Among the high-grade ductal carcinoma in situ cases, a triple-positive profile (positive for estrogen receptor, progesterone receptor, and HER2) and cytokeratin 5/6 expression

Figure 1 - Bone marrow replaced with metastatic breast ductal carcinoma, H&E stain, original magnification 200X. Figure 2 - GCDFP-15 positive breast ductal carcinoma

Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the

Survivin protein immunoexpression was significantly more elevated in epithelial cells of high-grade breast ductal carcinoma in situ as compared to low-grade lesions.. There was